0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover1947.39%IV4.82%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5789Delta0.3876Gamma--Leverage Ratio-5.3750Theta0.0000Rho0.00Eff Leverage0.0002Vega
EDAP TMS Stock Discussion
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
EDAP TMS SA (Nasdaq: EDAP) announced interim results from its Phase 3 study evaluating robotic High-Intensity Focused Ultrasound (HIFU) therapy for deep infiltrating endometriosis.
The study, involving 60 patients, aimed to assess acute pelvic pain levels. Key findings include:
1. Robotic HIFU therapy maintained an excellent safety profile, confi...
In reaction to earnings/guidance:
• $CalAmp(CAMP.US)$ +0.6%
Other news:
• $Cano Health(CANO.US)$ +6.1% ( $Humana(HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept Therapeutics(CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial(LPLA.US)$ +4.1% (reports monthly activity for August)
• $Dentsply Sirona(XRAY.US)$ +3% (names new CFO)
• $iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +2.9% (tr...
$Alcoa(AA.US)$ $Avenue Therapeutics(ATXI.US)$ $Alibaba(BABA.US)$ $HeartBeam(BEAT.US)$ $Costco(COST.US)$ $EDAP TMS(EDAP.US)$ $FedEx(FDX.US)$ $Eli Lilly and Co(LLY.US)$ $Spero Therapeutics(SPRO.US)$ $Top Ships(TOPS.US)$ $T2 Biosystems(TTOO.US)$
No comment yet